Stroke Symptoms Associated with Developing Memory and Thinking Problems
“‘Silent strokes’ that cause small areas of brain damage have been tied to memory and thinking problems, but it has been difficult to study these ‘silent strokes’ due to the cost and inconvenience of obtaining brain MRIs,” said study author Brendan J. Kelley, MD, of the University of Cincinnati and a member of the American Academy of Neurology. “With this study, we found that a quick, seven-question test can be a cost-effective tool to help identify people at increased risk of developing dementia.”
For the research, 23,830 people from the REGARDS study with an average age of 64 with no memory problems who had never had a stroke completed the stroke symptoms questionnaire at the start of the study and every six months for at least two years. The questionnaire asks about symptoms of stroke or transient ischemic attack (TIA), or a “mini-stroke” where symptoms resolve quickly with no permanent damage. The participants’ memory and thinking skills were also tested yearly. During the study, 7,223 people had stroke symptoms.
The study found that people who had stroke symptoms were more likely to develop memory and thinking problems. Caucasians who had stroke symptoms were twice as likely to develop cognitive problems (11 percent) as Caucasians who did not have stroke symptoms (5 percent). African-Americans who had stroke symptoms were nearly 70 percent as likely to develop thinking problems (16 percent) as African-Americans who did not have stroke symptoms (about 10 percent).
“Our study highlights the importance of discussing stroke-like symptoms with your family doctor, even if they don't last long. These symptoms can be a warning sign that a person is at increased risk of stroke or problems with thinking or memory,” said Kelley.
The REGARDS study was supported by the National Institute of Neurological Disorders and Stroke, National Institutes of Health and Department of Health and Human Services.
Source: American Academy of Neurology
Published on : Thu, 20 Jun 2013
Print as PDF
XENIOS AG is a medical device company with the three brands, novalung, i-cor and medos, that run on a single XENIOS platform. This platform enables next-generation therapies for lung and heart failure. No other company except XENIOS AG is offering lung...
The technical and clinical reference standard for all B·R·A·H·M·S PCT assays. All clinical cut-offs and algorithms were developed based on B·R·A·H·M·S PCT sensitive KRYPTOR. Homogeneous immunoassay for the quantitative d
Medos customized tubing sets have been individually designed, so that all customer requirements, depending on application and need can be realized. Furthermore tubing sets can be refined by rheoparin or x.eed coating.
The fully featured ICU ventilator, HAMILTON-MR1, guarantees uncompromised continuous ventilation care from the ICU to the MRI scanner and back. Its reliability and high performance, with advanced lung-protective strategies and patient-adaptive modes,...
NovaPort cannulas are designed specially to meet the needs of extracorporeal lung and heart support circuits and perioperative perfusion in minimally invasive heart surgery.All blood-contact surfaces of the NovaPort cannulas are coated with the bio- and...